GHK-Cu (copper peptide GHK-Cu, or glycyl-L-histidyl-L-lysine:copper(II)) is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine
GHKCu acetate
Jastreboff, MD, PhD Director, Weight Management & Obesity Prevention Yale School of Medicine, New Haven, Connecticut Professor Ania Jastreboff has been a principal investigator for pivotal GLP3 clinical trials, including the landmark phase 2 obesity study published in the New England Journal of Medicine
The peptide accelerates the healing of fractures as well as various bone defects and losses
This origin has a profound practical consequence: unlike nearly all other research peptides, the BPC-157 peptide is resistant to hydrolysis and enzymatic degradation in gastric conditions
This represents an average additional fat loss of about 1.8 kg (4 pounds) over 12 weeks attributable to the peptide